Feb 05, 2019 OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes MORE >>
Feb 01, 2019 OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer MORE >>
Jan 31, 2019 OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator MORE >>
SEC Filing Details Document Details Form 4 Filing Date Aug 27, 2018 Document Date Aug 24, 2018 Form Description Statement of changes in beneficial ownership of securities Filing Group 3,4,5 Company OPKO Health, Inc. Filer FROST PHILLIP MD ET AL Filing Formats View HTML Download PDF Download DOC